Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2008-08-21 |
| Study Made Public: | 2012-06-15 |
Title
Weiss mAbs potency
Description
CAVD 235 is a monoclonal antibody study to characterize mAbs isolated and produced from IgG+ memory B cells of non-clade B HIV-1 infected donors, using a representative panel of HIV-1 primary isolates.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.